Cleveland Clinic Lerner College of MedicineDisclosures
Dr. Cohen reports receiving consulting fees from Biogen Idec, Novartis, EMD Serono, and Teva; lecture fees from Sanofi-Aventis and Waterfront Media; and research support from Genzyme, Novartis, and Teva.
Dr. Jeffrey Cohen is the director of the Mellen Center Experimental Therapeutics program at the Cleveland Clinic in Cleveland, Ohio. He is also a staff member at the Mellen MS Center in the department of neurology at the Cleveland Clinic. Dr. Cohen is the chair of the clinical fellowship review committee for the National MS Society and a member of the executive committee on the clinical advisory board. He is also a member of the Neurological Institute Research Committee at the Cleveland Clinic Foundation.
You need to be logged in to save this episode to a playlist.
You must be logged in to display playlists.